Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study.
Vergnenègre A, Monnet I, Chouaïd C, Hureaux J, Mazières J, Quéré G, Lombard JN, Cumin I, Abdiche S, Ejnaini CN, Bonnabau H, Decroisette Ch; GFPC team.
Vergnenègre A, et al. Among authors: hureaux j.
Lung Cancer. 2011 Nov;74(2):264-7. doi: 10.1016/j.lungcan.2011.03.007. Epub 2011 May 14.
Lung Cancer. 2011.
PMID: 21571389